NeuroLutions
NeuroLutions is a medical device company developing brain-computer interface (BCI) technology for stroke rehabilitation. The company's flagship product, IpsiHand, is an FDA-cleared, non-invasive at-home therapy system that helps chronic stroke survivors regain arm and hand function. The system comprises three components: a wireless EEG headset that measures electrical signals from the uninjured brain hemisphere to…
Funding snapshot
About
NeuroLutions is a medical device company developing brain-computer interface (BCI) technology for stroke rehabilitation. The company's flagship product, IpsiHand, is an FDA-cleared, non-invasive at-home therapy system that helps chronic stroke survivors regain arm and hand function. The system comprises three components: a wireless EEG headset that measures electrical signals from the uninjured brain hemisphere to capture the patient's intention to move, a powered handpiece that moves the affected hand open and closed based on brain signals, and a tablet that guides therapy sessions and tracks progress. Clinical trial participants showed approximately 70% improvement in arm and hand movement, with an average improvement of 8.1 points on the Fugl-Meyer Assessment after 12 weeks of use. IpsiHand is covered by Medicare, the VA, and many health plans. Founded in 2007 and headquartered in St. Louis, Missouri, NeuroLutions has raised approximately $28.3 million in Series A funding from investors including Prolog Ventures, Ascension Ventures, BioGenerator, HHS, and AMED Ventures.
Business model
Brain Computer Interface > Applications > Healthcare > Rehabilitation,
Healthcare IT > Value Based Care > Patient Engagement > Digital Therapeutics > Physiotheraphy > Neurorehabilitation,
Neurology > Medical Devices > Therapeutic Devices > Stroke Rehabilitation
Founders & team highlights
Serial Founder
Team background
Top Rated Teams > Serial Entrepreneur
Institutional investors
Latest coverage
No articles yet.
Similar startups
NovaHealth AI
NovaHealth AI automates visit summaries, coding suggestions, and prior-authorization drafts for mid-sized provider groups.
ScreenPoint
Developer of artificial intelligence software for analyzing breast imaging mammograms. This technology integrates with existing medical imaging hardware to assist radiologists in detecting cancer.
Bioz
Developer of AI search engine for scientific experimentation.
Rad AI
Developer of radiology artificial intelligence software for workflow and reporting. The software aims to improve efficiency and reduce fatigue for radiologists.